Scotiabank initiated coverage on Absci Corporation with a new price target
$ABSI
Biotechnology: Commercial Physical & Biological Resarch
Health Care
Scotiabank initiated coverage of Absci Corporation with a rating of Sector Outperform and set a new price target of $13.00